Director Trades
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
News
Corporate: Zelda director sells stock after board promises not to sell stock
Health & Biotech
Health: Pharmaxis on verge of $14.3m payout after FDA close call on Bronchitol
News
Weed Week: Has pot *really* gone from Pineapple Express to luxury status symbol?
The Pot Seat: Zelda’s Richard Hopkins says registering pot drugs is a luxury
News
Tl;dr? Here are your Budget cliff notes on what’s in store for ASX small caps
News
These are the ASX small caps that might benefit from the Budget
Check-up: What’s happening with the ASX small cap health stocks?
Health & Biotech
Pot stock Zelda is coming to America – someday – after signing a pharma deal
Health & Biotech
Harry Karelis wants to turn ex-tech wreck 1 Page into a pot stock worth as much as all the ASX pot stocks combined
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Zelda might have found way forward for diagnosing breast cancer
Health & Biotech
The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs
Health & Biotech
Zelda’s looking for experts to help with its cannabis trials on kids and insomniacs
Health & Biotech
If pot is so hot, why aren’t cannabis directors buying their own companies?
News
Lunchtime ASX small cap wrap: who’s nursing a new years hangover
Health & Biotech
